Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Biomedical Materials Research. Part A

• Publication date

  2008-06-15

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1002/JBM.A.31599PMID 17907244PMCID PMC2743543
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• La Substance Minérale Dans les Os

  2010cited by this paper
• Novel insights into actions of bisphosphonates on bone: differences in interactions with hydroxyapatite.

  2006cited by this paper
• A computational model delineates differences in hydroxyapatite binding affinities of bisphosphonates in clinical use

  2005cited by this paper
• First Principles Investigation of Mineral Component of Bone: CO3 Substitutions in Hydroxyapatite

  2005cited by this paper
• Composition of bone and apatitic biomaterials as revealed by intravital Raman microspectroscopy.

  2005cited by this paper
• Age-related changes in physicochemical properties of mineral crystals are related to impaired mechanical function of cortical bone.

  2004cited by this paper
• Constant composition kinetics study of carbonated apatite dissolution

  2003cited by this paper
• Alendronate zwitterions bind to calcium cations arranged in columns.

  2003cited by this paper
• Biological and medical significance of calcium phosphates.

  2002cited by this paper
• Acute acidosis-induced alteration in bone bicarbonate and phosphate.

  2002cited by this paper
• Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.

  2001cited by this paper
• Bisphosphonates in Bone Disease: From the Laboratory to the Patient

  2000cited by this paper
• Solid‐state NMR of bisphosphonates adsorbed on hydroxyapatite

  2000cited by this paper
• Relationships Among Carbonated Apatite Solubility, Crystallite Size, and Microstrain Parameters

  1999cited by this paper
• Synthesis, Characterization, and Crystal Structure of Dicalcium Glutarylbis(phosphonate) Dihydrate: A Covalently Pillared Layer Structure with the Potential for Epitaxial Growth on Hydroxyapatite.

  1998cited by this paper
• Chemical and structural characterization of the mineral phase from cortical and trabecular bone.

  1997cited by this paper
• Bisphosphonate on bones

  1995cited by this paper
• An FTIR study of carbonate in synthetic apatites

  1992cited by this paper
• Bone structure: from ångstroms to microns

  1992cited by this paper
• Calcium phosphates in oral biology and medicine.

  1991cited by this paper
• Determination of carbonate carbon in geological materials by coulometric titration

  1985cited by this paper
• Kinetics of dissolution of calcium hydroxyapatite: V. The acidity constant for the hydrogen phosphate surface complex

  1982cited by this paper
• Apatites in biological systems

  1981cited by this paper
• Mineralization Kinetics: A Constant Composition Approach

  1978cited by this paper
• The growth of crystals and the equilibrium structure of their surfaces

  1951cited by this paper
• Quantitative Chemical Analysis

  1944cited by this paper
• ADSORPTION OF GASES IN MULTIMOLECULAR LAYERS

  1938cited by this paper

• Bisphosphonates loaded nanoparticles in microparticles: a potential macrophage targeting and repolarizing drug delivery system

  2025cites this paper
• Atypical Femoral Fracture Secondary to Long-Term Bisphosphonate Use: A Case Report

  2025cites this paper
• Recent advances in montmorillonite-based composites for biomedical applications: A review

  2025cites this paper
• Clinically relevant doses of tiludronate do not affect bone remodelling in pasture‐exercised horses

  2024cites this paper
• Multiple Myeloma and the Role of Bisphosphonates in Its Management

  2023cites this paper
• Modified-Hydroxyapatite-Chitosan Hybrid Composite Interfacial Coating on Three-Dimensional Polymeric Scaffolds for Bone Tissue Engineering.

  2023cites this paper
• Inhibition of osteoclastogenesis after bisphosphonate therapy discontinuation: an in vitro approach

  2022cites this paper
• Bisphosphonates as Potential Inhibitors of Calcification in Bioprosthetic Heart Valves (Review)

  2022cites this paper
• Rapid Flow Synthesis of a Biomimetic Carbonate Apatite as an Effective Drug Carrier.

  2022cites this paper
• The Impact of COVID-19 on the Optimal Management of Osteoporosis

  2021cites this paper
• Management of patients under Bone Anti-Resorptive Drugs- A Survey among Dental Practitioners

  2021cites this paper
• Inhibition of zoledronic acid derivatives with extended methylene linkers on osteoclastogenesis involve downregulation of JNK and Akt pathways

  2021cites this paper
• A Biomimetic Biphasic Osteochondral Scaffold with Layer‐Specific Release of Stem Cell Differentiation Inducers for the Reconstruction of Osteochondral Defects

  2020cites this paper
• Denosumab for cancer-related bone loss

  2020cites this paper
• Nanostructured calcium phosphates for hard tissue engineering and nanomedicine

  2020cites this paper
• Mesoporous Silica Nanoparticles for the Treatment of Complex Bone Diseases: Bone Cancer, Bone Infection and Osteoporosis

  2020cites this paper
• Dual Delivery of Alendronate and E7-BMP-2 Peptide via Calcium Chelation to Mineralized Nanofiber Fragments for Alveolar Bone Regeneration.

  2020cites this paper
• Empirical and theoretical insights into the structural effects of selenite doping in hydroxyapatite and the ensuing inhibition of osteoclasts.

  2020cites this paper
• Osteoporosis Management in the Era of COVID‐19

  2020cites this paper
• Predicting binding affinities of nitrogen-containing bisphosphonates on hydroxyapatite surface by molecular dynamics

  2019cites this paper
• Novel hybrid chitosan/calcium phosphates microgels for remineralization of demineralized enamel – A model study

  2019cites this paper
• Novel structures of platinum complexes bearing N‑bisphosphonates and study of their biological properties.

  2019cites this paper
• Clinical evidence of the effect of bisphosphonates on pregnancy and the infant

  2019cites this paper
• Biomaterials as carriers for bone active molecules-An approach to create off-the-shelf bone substitutes

  2018cites this paper
• Using Molecular Dynamics to Model the Binding Affinities of Nitrogen-Containing Bisphosphonates on Hydroxyapatite Surface

  2018cites this paper
• Interactions between Clinically Used Bisphosphonates and Bone Mineral: from Coordination Chemistry to Biomedical Applications and Beyond

  2018cites this paper
• Prophylactic Bisphosphonate Therapy to Reduce Glucocorticoid-Induced Osteoporosis in a Mouse Model of Duchenne Muscular Dystrophy

  2018cites this paper
• Anticalcification potential of heparin on hydroxyapatite seeds using a constant composition in vitro model

  2018cites this paper
• Treating Osteoporosis: Localized Drug Delivery into Femur

  2017cites this paper
• Hydroxyapatite as a nanomaterial for tissue engineering and drug therapy

  2017cites this paper
• Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS.

  2017cites this paper
• Hydroxyapatite as a Nanomaterial for Advanced Tissue Engineering and Drug Therapy.

  2017cites this paper
• Targeted delivery to bone and mineral deposits using bisphosphonate ligands.

  2016cites this paper
• Physiologic Activity of Bisphosphonates – Recent Advances

  2016cites this paper
• Preparation of collagen/hydroxyapatite/alendronate hybrid hydrogels as potential scaffolds for bone regeneration.

  2016cites this paper
• pH-activated nanoparticles for controlled topical delivery of farnesol to disrupt oral biofilm virulence.

  2015cites this paper
• Structural requirements for bisphosphonate binding on hydroxyapatite: NMR study of bisphosphonate partial esters.

  2015cites this paper
• Modification of Hydroxyapatite with Ion-Selective Complexants: 1-Hydroxyethane-1,1-diphosphonic Acid

  2014cites this paper
• Bone quality of the newest bone formed after two years of teriparatide therapy in patients who were previously treatment-naïve or on long-term alendronate therapy

  2014cites this paper
• Evaluation of maleic acid based polymers as scale inhibitors and dispersants for industrial water applications

  2014cites this paper
• Modifications de la composition et de la structure moléculaire du tissu osseux sous l'influence des bisphosphonates

  2014cites this paper
• Implications of the use of bisphosphonates in dental treatment - experience of the service of oral and maxillofacial surgery, Erasto Gaertner Hospital, Curitiba, Brazil

  2013cites this paper
• New developments in polymer-controlled, bioinspired calcium phosphate mineralization from aqueous solution.

  2013cites this paper
• Physicochemical, pharmacologic, and in vitro cellular effects of loading collagen membranes with zoledronic acid.

  2013cites this paper
• Equilibrium-dependent bisphosphonate interaction with crystalline bone mineral explains anti-resorptive pharmacokinetics and prevalence of osteonecrosis of the jaw in rats.

  2013cites this paper
• A Series of Imidazolyl-Containing Bisphosphonates with Abundant Hydrogen-Bonding Interactions: Syntheses, Structures, and Bone-Binding Affinity

  2013cites this paper
• Equilibrium-dependent bisphosphonate interaction with crystalline bone mineral explains the pharmacokinetics and osteonecrosis of the jaw in rats

  2013cites this paper
• Effects of alendronate and risedronate on bone material properties in actively forming trabecular bone surfaces

  2012cites this paper
• The effect of zoledronate-hydroxyapatite nanocomposites on osteoclasts and osteoblast-like cells in vitro.

  2012cites this paper
• Effects of 3 years treatment with once-yearly zoledronic acid on the kinetics of bone matrix maturation in osteoporotic patients

  2012cites this paper
• Influence of bone affinity on the skeletal distribution of fluorescently labeled bisphosphonates in vivo

  2012cites this paper
• Bone material properties in actively bone‐forming trabeculae in postmenopausal women with osteoporosis after three years of treatment with once‐yearly Zoledronic acid

  2011cites this paper
• Infrared Assessment of Bone Quality: A Review

  2011cites this paper
• Denosumab and bisphosphonates: different mechanisms of action and effects.

  2011cites this paper
• Effects of one year daily teriparatide treatment on trabecular bone material properties in postmenopausal osteoporotic women previously treated with alendronate or risedronate.

  2011cites this paper
• Bisphosphonates, specific inhibitors of osteoclast function and a class of drugs for osteoporosis therapy

  2011cites this paper
• In-vivo near-infrared optical imaging of growing osteosarcoma cell lesions xenografted in mice: dual-channel quantitative evaluation of volume and mineralization

  2011cites this paper
• pH Tunable Fluorescent Calcium Phosphate Nanocomposite for Sensing and Controlled Drug Delivery

  2011cites this paper
• An in vitro Assay to Measure Targeted Drug Delivery to Bone Mineral

  2010cites this paper
• Bisphosphonate treatment modifies canine bone mineral and matrix properties and their heterogeneity.

  2010cites this paper
• Bisphosphonates: molecular mechanisms of action and effects on bone cells, monocytes and macrophages.

  2010cites this paper
• Functionalization of biomimetic calcium phosphate bone cements with alendronate.

  2010cites this paper
• Differences between bisphosphonates in binding affinities for hydroxyapatite.

  2010cites this paper
• Are All Bisphosphonates the Same? Potential Reasons for Clinical Differences: A Perspective

  2010cites this paper
• Biomimetic Ca-P coatings incorporating bisphosphonates produced on starch-based degradable biomaterials.

  2010cites this paper
• Alendronate and Pamidronate calcium phosphate bone cements: setting properties and in vitro response of osteoblast and osteoclast cells.

  2009cites this paper
• Prolonged osteogenesis from human mesenchymal stem cells implanted in immunodeficient mice by using coralline hydroxyapatite incorporating rhBMP2 microspheres.

  2009cites this paper
• Fluorescent Risedronate Analogues Reveal Bisphosphonate Uptake by Bone Marrow Monocytes and Localization Around Osteocytes In Vivo

  2009cites this paper
• Chapter 81 – Bisphosphonates: Mechanisms of Action

  2008cites this paper
• An update on the pharmacology of bisphosphonates and analogues with lower bone affinity

  2008cites this paper
• Bisphosphonates: how do they work?

  2008cites this paper
• Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

  2008cites this paper